News

Melanoma Research Alliance Applauds FDA Approval of First Cellular Therapy in Melanoma

16 February 2024 In Events, News, Treatment

The Melanoma Research Alliance (MRA), the largest non-profit funder of melanoma research worldwide, welcomes the U.S. Food and Drug Administration (FDA) decision to approve Iovance Biotherapeutics’ AMTAGVITM (lifileucel) for the treatment of patients with advanced melanoma in the second line treatment setting.

Read More


Melanoma Immunotherapies & Immune-related Adverse Events: A Conversation with Dr. Alexandra-Chloé Villani

By Tanisha Jackson, PhD - MRA Scientific Program Director | 5 February 2024 In Allies & Partnerships, Events, Science, Treatment

Immune-related adverse events (irAEs) are side effects experienced by patients undergoing immunotherapy to treat their melanoma (or other cancer). In November, at the annual Society for Immunotherapy of Cancer (SITC) meeting, we spoke with Dr. Alexandra-Chloé Villani, an MRA-funded investigator at Massachusetts General Hospital, to learn more about immune-related adverse events and the research she leads in this area.

Read More


100,000 Americans Estimated to be Diagnosed with Invasive Melanoma in 2024

By Joan Levy, PhD - MRA Chief Science Officer | 26 January 2024 In News, Prevention, Science, Treatment

Each January, the American Cancer Society (ACS) releases updated estimates about trends in new cancer cases and deaths in its annual report, Cancer Facts and Figures. This report highlights the estimated incidence (number of new cases), prevalence (number of people alive today with a history of cancer), and survival statistics for...

Read More


Where Innovation Meets Impact: MRA 2023 Annual Report

23 January 2024 In Allies & Partnerships, Events, Melanoma Stories, News, Policy, Prevention, Science, Treatment

MRA is a world leader in advancing transformational science that has caused paradigm shifts in what it means to be diagnosed with and treated for melanoma. The innovative research we support isn’t just changing science — it’s giving patients more treatment options that translate to longer, fuller lives.

Read More


Overcoming Brain Mets & LMD: Sean Wachter’s Melanoma Journey

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 22 January 2024 In Melanoma Stories, Science, Treatment

Ten years ago, Sean Wachter never expected to have a loving spouse, children, or a life that feels worth living. That’s because, by his own admission, he’s done more living in the past 7 years than he did in the prior 31 as he overcame stage 4 melanoma with leptomeningeal disease...

Read More


New Research Alert: Melanoma and Microbiota: Current Understanding and Future Directions

8 January 2024 In Allies & Partnerships, Events, News, Science, Treatment

A perspective article summarizing the field’s current knowledge on how the gut microbiota affects melanoma response to immunotherapy, and how this knowledge can be used to improve patient outcomes was recently published in the journal Cancer Cell. 

Read More


Mindfulness During the Holidays: Tips for the Melanoma Community

By Stephanie Kauffman, MRA President & COO | 14 December 2023 In Allies & Partnerships, Events

While the holidays are a time to celebrate with family and friends, the season can quickly go from joyful to stressful for those living with a melanoma diagnosis. We have some suggestions on navigating the holidays

Read More


Clinical Trials to Watch: December 2023

By Joan Levy, PhD - MRA Chief Science Officer | 13 December 2023 In Allies & Partnerships, News, Science, Treatment

Treatment of advanced melanoma has dramatically improved over the past decade with 16 new therapies approved by the Food and Drug Administration (FDA). Even with these treatment advances, 50% of patients with advanced melanoma will either not respond to any of these treatments or their disease will progress creating a...

Read More


Shop for the Holidays and Give Back to MRA

By Laurel Farr, MRA Development Associate | 12 December 2023 In Allies & Partnerships, Events

The MRA community has given us so much throughout 2023 and we wanted to give back this holiday season with some tips, ideas, and discounts to help make your holiday gift-giving more meaningful and memorable. MRA’s incredible partners offer fantastic products that not only make thoughtful presents but also contribute to melanoma research. Here is our quick guide to meaningful and memorable gifts with special discounts for the MRA community.

Read More


Registration Now Open: MRA's 2024 Patient Forum

11 December 2023 In Allies & Partnerships, Events, Melanoma Stories, News, Policy, Prevention, Science, Treatment

Registration for MRA's Melanoma Exchange Patient Forum, held in-person in Washington DC and virtually on Wednesday, February 21, is now open. Register now to hear from leading experts in the melanoma field and have the opportunity to ask questions, discuss, and network with other people who are going through their own melanoma journey.

Read More


Login

×